While the enhancement of SIRT1 expression has advantages in MIRI treatment, extreme overexpression of SIRT1 has been reported to lead to disadvantages such as hypertrophy and cardiac dysfunction. The gene discussed is SIRT1; the disease is cardiac hypertrophy.